<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00637156</url>
  </required_header>
  <id_info>
    <org_study_id>PRESTIGE LP Two Level Study</org_study_id>
    <nct_id>NCT00637156</nct_id>
  </id_info>
  <brief_title>Study of the Safety and Effectiveness of the Artificial Cervical Disc - Low Profile Device at Two Adjacent Levels</brief_title>
  <official_title>A Prospective, Randomized, Controlled, Multicenter Pivotal Clinical Trial of the Artificial Cervical Disc-LP at Two Levels for Symptomatic Cervical Disc Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Spinal and Biologics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Spinal and Biologics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical investigation is to assess the safety and effectiveness of using
      the PRESTIGE-LP device in the treatment of patients with symptomatic degenerative disc
      disease at two adjacent levels of the cervical spine, with overall success being the primary
      endpoint of the clinical trial. The primary objective is to show non-inferiority of the
      investigational device to the control treatment. If non-inferiority is established,
      superiority will also be examined as the secondary objective.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This clinical investigation is being conducted to evaluate the PRESTIGE-LP device's
      performance at two adjacent cervical levels (C3-C7) in the treatment of patients with
      symptomatic degenerative disc disease. One-half of the patients in this randomized pivotal
      clinical trial will be treated at two adjacent cervical levels with the PRESTIGE-LP device.
      The remaining patients will receive a bi-level anterior cervical discectomy and fusion with
      cortical ring allografts and the ATLANTIS Cervical Plate System.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">February 1, 2018</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Overall Success</measure>
    <time_frame>24 Months</time_frame>
    <description>Rate of overall success is reported as the percentage of participants who met all of the following criteria:
Postoperative Neck Disability Index (NDI) score improvement of at least a 15-point increase from preoperative;
Maintenance or improvement in neurological status;
No serious adverse event classified as implant associated or implant/surgical procedure associated; and
No additional surgical procedure classified as a &quot;failure.&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success Rate of Neck Disability Index</measure>
    <time_frame>24 months</time_frame>
    <description>Success rate of Neck Disability Index is reported as the percentage of participants whose neck disability index score met the following criterion: Pre-treatment Score - Post-treatment Score ≥ 15.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success Rate of Neurological Status</measure>
    <time_frame>24 months</time_frame>
    <description>Success rate of neurological status is reported as the percentage of participants who met neurological success defined as maintenance or improvement in all sections (motor, sensory, and reflexes) for the time period evaluated. In order for a section to be considered a success, each element in the section must either remain the same or improve from the time of the preoperative evaluation to the time period evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neck Pain Success Rate</measure>
    <time_frame>24 months</time_frame>
    <description>Numerical rating scales were used to evaluate pain intensity and frequency. The pain score (0 min, 20 max) was derived by adding the numerical rating scores from the pain intensity (0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot;) and frequency scales (0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time&quot;). Neck pain success rate is reported as the percentage of participants whose neck pain improvement met the following criterion: Preoperative Score - Postoperative Score &gt; 0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arm Pain Success Rate</measure>
    <time_frame>24 months</time_frame>
    <description>Numerical rating scales were used to evaluate pain intensity and frequency. The pain score (0 min, 20 max) was derived by adding the numerical rating scores from the pain intensity (0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot;) and frequency scales (0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time&quot;). Arm pain success rate is reported as the percentage of participants whose arm pain improvement met the following criterion: Preoperative Score - Postoperative Score &gt; 0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success Rate of SF-36 PCS</measure>
    <time_frame>24 months</time_frame>
    <description>Success rate of SF-36 Health Survey include two components: the success rate of a physical component summary (PCS) and the success rate of a mental component summary (MCS). The success of SF-36 PCS was defined as: Post Score - Pre Score &gt;= 0. The Success rate of SF-36 PCS is reported as the percentage of the participants who were classified as a success for SF-36 PCS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success Rate of SF-36 MCS</measure>
    <time_frame>24 months</time_frame>
    <description>Success rate of SF-36 Health Survey include two components: the success rate of a physical component summary (PCS) and the success rate of a mental component summary (MCS). The success of SF-36 MCS were defined as: Post Score - Pre Score &gt;= 0. The Success rate of SF-36 MCS is reported as the percentage of the participants who were classified as a success for SF-36 MCS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Disc Height Success</measure>
    <time_frame>24 months</time_frame>
    <description>Disc height was assessed by determining the Functional Spinal Unit (FSU) height. The rate of disc height success is reported as the percentage of participants whose disc height for each level based on either the anterior or posterior measurements met the following criterion: Postoperative Height - 6 Week Postoperative Height &gt;= -2mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait Success Rate</measure>
    <time_frame>24 months</time_frame>
    <description>Patient's gait was assessed by using Nurick's classification, and indicated either as normal or graded on a scale of 0 to 5. Success was defined as maintenance or improvement in the postoperative status as compared to the preoperative condition: Preoperative Score - Postoperative Score &gt;= 0. The gait success rate is reported as the percentage of participants who had gait success.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative Time</measure>
    <time_frame>Time of operation, an average of 1.7-2.1hrs</time_frame>
    <description>Operative time was recorded from skin incision to wound closure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Loss</measure>
    <time_frame>During the time of operation, an average of 1.7-2.1 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Stay</measure>
    <time_frame>From admission to discharge, an average of 1.0-1.5 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Secondary Surgery at Index Level</measure>
    <time_frame>24 months</time_frame>
    <description>Secondary surgical procedures at the index level included revisions, removals, supplemental fixations and reoperations. Rate of secondary surgery at index level is reported as percentage of subjects who had secondary surgeries at index level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Neck Disability Index Score From Baseline</measure>
    <time_frame>Baseline and 24 months post-operation</time_frame>
    <description>The self-administered Neck Disability Index (NDI) Questionnaire was used to assess patient neck pain and ability to function. The NDI scale ranges from 0-100. The best score is 0 (no disability) and worst is 100 (maximum disability). Change of NDI was defined as NDI at 24 month minus NDI at baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Neck Pain Score From Baseline</measure>
    <time_frame>Baseline and 24 months post-operation</time_frame>
    <description>Numerical rating scales were used to evaluate neck pain intensity and frequency. Subjects rated their neck pain intensity on a scale from 0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot; Similarly, subjects recorded their neck pain frequency on a scale from 0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time.&quot; The total neck pain score (0 to 20) was the addition of pain intensity and frequency scores. Change of neck pain score was defined as neck pain score at 24 months minus neck pain score at baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Arm Pain Score From Baseline</measure>
    <time_frame>Baseline and 24 months post-operation</time_frame>
    <description>Numerical rating scales were also used to evaluate arm pain intensity and frequency. Subjects rated their arm pain intensity on a scale from 0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot; Similarly, subjects recorded their arm pain frequency on a scale from 0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time.&quot; The total arm pain score (0 to 20) was the addition of pain intensity and frequency scores. Change of arm pain score was defined as arm pain score at 24 months minus arm pain score at baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of General Health Status -- SF-36 PCS From Baseline</measure>
    <time_frame>Baseline and 24 months post-operation</time_frame>
    <description>The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results were summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS was between 0 and 100, with higher scores denoting better quality of life. Change of SF-36 PCS score was defined as PCS score at 24 months minus PCS score at baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of General Health Status -- SF-36 MCS From Baseline</measure>
    <time_frame>Baseline and 24 months post-operation</time_frame>
    <description>The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results were summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for MCS was between 0 and 100, with higher scores denoting better quality of life. Change of SF-36 MCS score was defined as MCS score at 24 months minus MCS score at baseline.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">397</enrollment>
  <condition>Cervical Degenerative Disc Disease</condition>
  <condition>Radiculopathy</condition>
  <condition>Myelopathy</condition>
  <arm_group>
    <arm_group_label>PRESTIGE LP Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ATLANTIS Cervical Plate System</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PRESTIGE LP device at two adjacent levels</intervention_name>
    <description>PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
    <arm_group_label>PRESTIGE LP Device</arm_group_label>
    <other_name>disc</other_name>
    <other_name>artificial disc</other_name>
    <other_name>cervical disc</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bi-level fusion with ATLANTIS Cervical Plate System</intervention_name>
    <description>Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
    <arm_group_label>ATLANTIS Cervical Plate System</arm_group_label>
    <other_name>plate</other_name>
    <other_name>cervical plate</other_name>
    <other_name>fusion</other_name>
    <other_name>cervical fusion</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Has cervical DDD at 2 adjacent cervical levels (C3-C7) requiring surgical treatment &amp;
             involving intractable radiculopathy, myelopathy, or both

          -  Has a herniated disc and/or osteophyte formation at each level to be treated that is
             producing symptomatic nerve root and/or spinal cord compression. The condition is
             documented by patient history, and the requirement for surgical treatment is evidenced
             by radiographic studies

          -  Unresponsive to non-operative treatment for approximately 6 weeks or has the presence
             of progressive symptoms or signs of nerve root/spinal cord compression in the face of
             continued non-operative management

          -  Has no previous surgical intervention at the involved levels or any subsequent
             planned/staged surgical procedure at the involved or adjacent level(s)

          -  Must be ≥ 18 years; skeletally mature at time of surgery

          -  Preoperative NDI score ≥ 30

          -  Preoperative neck pain score ≥ 8 based on the preoperative Neck and Arm Pain
             Questionnaire

          -  If a female of childbearing potential, patient is non-pregnant, non-nursing, and
             agrees not to become pregnant during the study period

          -  Is willing to comply with the study plan and sign Patient Informed Consent Form

        Exclusion Criteria:

          -  Has a cervical spinal condition other than symptomatic cervical DDD requiring surgical
             treatment at the involved levels

          -  Has documented or diagnosed cervical instability relative to adjacent segments at
             either level, defined by dynamic (flexion/extension) radiographs showing: Sagittal
             plane translation &gt; 3.5 mm, or Sagittal plane angulation &gt; 20 degrees.

          -  Has more than two cervical levels requiring surgical treatment

          -  Has a fused level adjacent to the levels to be treated

          -  Has severe pathology of the facet joints of the involved vertebral bodies

          -  Has had previous surgical intervention at either one or both of the involved levels or
             at adjacent levels

          -  Has been previously diagnosed with osteopenia or osteomalacia

          -  Has any of the following that may be associated with a diagnosis of osteoporosis (If
             &quot;Yes&quot; to any of the below a DEXA Scan will be required to determine eligibility.)

               -  Postmenopausal non-Black female over age of 60 who weighs &lt; 140 pounds

               -  Postmenopausal female who has sustained a non-traumatic hip, spine, or wrist
                  fracture

               -  Male &gt; 70 years

               -  Male &gt; 60 years who has sustained a non-traumatic hip or spine fracture

               -  If the level of BMD is a T score of -3.5 or lower or a T score of -2.5 or lower
                  with vertebral crush fracture, then the patient is excluded from the study

          -  Has presence of spinal metastases

          -  Has overt or active bacterial infection, either local or systemic

          -  Has insulin dependent diabetes

          -  Is a tobacco user who does not agree to suspend smoking prior to surgery

          -  Has chronic or acute renal failure or prior history of renal disease

          -  Has a documented allergy or intolerance to stainless steel, titanium, or a titanium
             alloy

          -  Is mentally incompetent (If questionable, obtain psychiatric consult)

          -  Is a prisoner

          -  Is pregnant

          -  Is an alcohol and/or drug abuser as defined by currently undergoing treatment for
             alcohol and/or drug abuse

          -  Is involved with current or pending litigation regarding a spinal condition

          -  Has received drugs that may interfere with bone metabolism within two weeks prior to
             the planned date of spinal surgery (e.g., steroids or methotrexate), excluding routine
             perioperative anti-inflammatory drugs

          -  Has a history of an endocrine or metabolic disorder known to affect osteogenesis
             (e.g., Paget's Disease, renal osteodystrophy, Ehlers-Danlos Syndrome, or osteogenesis
             imperfecta)

          -  Has a condition that requires postoperative medications that interfere with the
             stability of the implant, such as steroids. (This does not include low-dose aspirin
             for prophylactic anticoagulation and routine perioperative anti-inflammatory drugs.)

          -  Has received treatment with an investigational therapy within 28 days prior to
             implantation surgery or such treatment is planned during the 16 weeks following
             implantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John K Burkus, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hughston Clinic, P.C.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Orthopaedic Center; Crestwood Medical Center</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Todd Lanman, MD, FACS, A Professional Corp.;</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bone &amp; Spine Surgery</name>
      <address>
        <city>Colton</city>
        <state>California</state>
        <zip>92324</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>La Jolla Neurological Associates, AMC; Scripps Memorial Hospital La Jolla; Scripps Memorial Hospital Encinitas</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's Spine Center; St. Mary's Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Delaware Neurosurgical Group; Christiana Care Health Systems</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spinal Associates, Gulf Coast Hospital</name>
      <address>
        <city>Panama City</city>
        <state>Florida</state>
        <zip>32405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peachtree Neurosurgery, Northside Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Hughston Clinic, P.C., Hughston Hospital and Rehabilitation Center</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neuro Spine &amp; Pain Center; Lutheran Hospital</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals &amp; Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Great Lakes Neurosurgical; Spectrum Health East Campus</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Adams Neurosurgery; Mid Michigan Medical Center</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>West Bloomfield</city>
        <state>Michigan</state>
        <zip>48322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Orthopedic Center of St. Louis; Barnes Jewish West County Hospital</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montana Neuro Science Institute; St. Patrick's Medical Center</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University at Buffalo Neurosurgery, Inc. Kaleida Health-Buffalo General Medical center/Gates Vascular Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Buffalo Neurosurgery Group</name>
      <address>
        <city>West Seneca</city>
        <state>New York</state>
        <zip>14224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Crystal Clinic, Inc.; Akron General Medical Center</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44333</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Ohio Neurological Surgeons; Mt. Carmel East Hospital</name>
      <address>
        <city>Westerville</city>
        <state>Ohio</state>
        <zip>43081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Center Orthopaedic &amp; Neurosurgical Care &amp; Research</name>
      <address>
        <city>Bend</city>
        <state>Oregon</state>
        <zip>97701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OAA Orthopaedic Specialists</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allegheny Neurosurgery; Washington Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lexington Brain and Spine Institute</name>
      <address>
        <city>West Columbia</city>
        <state>South Carolina</state>
        <zip>29169</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Sports Medicine and Orthopaedics; Memorial Hospital</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Tennessee Brain &amp; Spine Center, Johnson City Medical Center</name>
      <address>
        <city>Johnson City</city>
        <state>Tennessee</state>
        <zip>37604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Texas Spine Institute; Health South Surgical Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Brain and Spine; Winchester Medical Center</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Virginia University; Ruby Memorial Hospital, WVU Hospitals, Inc.</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2008</study_first_submitted>
  <study_first_submitted_qc>March 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2008</study_first_posted>
  <results_first_submitted>August 2, 2016</results_first_submitted>
  <results_first_submitted_qc>September 27, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 18, 2016</results_first_posted>
  <disposition_first_submitted>December 7, 2011</disposition_first_submitted>
  <disposition_first_submitted_qc>December 7, 2011</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">December 22, 2011</disposition_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Symptomatic DDD at Two Adjacent Levels of cervical spine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
    <mesh_term>Radiculopathy</mesh_term>
    <mesh_term>Spinal Cord Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>PRESTIGE LP Device</title>
          <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
        </group>
        <group group_id="P2">
          <title>ATLANTIS Cervical Plate System</title>
          <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="209"/>
                <participants group_id="P2" count="188"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="199"/>
                <participants group_id="P2" count="164"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>PRESTIGE LP Device</title>
          <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
        </group>
        <group group_id="B2">
          <title>ATLANTIS Cervical Plate System</title>
          <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="209"/>
            <count group_id="B2" value="188"/>
            <count group_id="B3" value="397"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.1" spread="8.3"/>
                    <measurement group_id="B2" value="47.3" spread="7.7"/>
                    <measurement group_id="B3" value="47.2" spread="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                    <measurement group_id="B2" value="98"/>
                    <measurement group_id="B3" value="215"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="92"/>
                    <measurement group_id="B2" value="90"/>
                    <measurement group_id="B3" value="182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="195"/>
                    <measurement group_id="B2" value="172"/>
                    <measurement group_id="B3" value="367"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>inches</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.2" spread="3.9"/>
                    <measurement group_id="B2" value="67.6" spread="4.0"/>
                    <measurement group_id="B3" value="67.4" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>lbs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="182.1" spread="42.6"/>
                    <measurement group_id="B2" value="186.3" spread="37.2"/>
                    <measurement group_id="B3" value="184.0" spread="40.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.2" spread="5.6"/>
                    <measurement group_id="B2" value="28.6" spread="4.9"/>
                    <measurement group_id="B3" value="28.4" spread="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Marital Status</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Single</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Married</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="146"/>
                    <measurement group_id="B2" value="133"/>
                    <measurement group_id="B3" value="279"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Divorced</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Separated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Widowed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Education Level</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;High school</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>High school</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;High school</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="104"/>
                    <measurement group_id="B3" value="229"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Worker's Compensation</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="183"/>
                    <measurement group_id="B2" value="169"/>
                    <measurement group_id="B3" value="352"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Unresolved Spinal litigation</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="209"/>
                    <measurement group_id="B2" value="187"/>
                    <measurement group_id="B3" value="396"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Alcohol Used</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="116"/>
                    <measurement group_id="B2" value="88"/>
                    <measurement group_id="B3" value="204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preoperative Work Status</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="146"/>
                    <measurement group_id="B2" value="113"/>
                    <measurement group_id="B3" value="259"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="75"/>
                    <measurement group_id="B3" value="138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Rate of Overall Success</title>
        <description>Rate of overall success is reported as the percentage of participants who met all of the following criteria:
Postoperative Neck Disability Index (NDI) score improvement of at least a 15-point increase from preoperative;
Maintenance or improvement in neurological status;
No serious adverse event classified as implant associated or implant/surgical procedure associated; and
No additional surgical procedure classified as a “failure.”</description>
        <time_frame>24 Months</time_frame>
        <population>The primary analysis dataset for this study included all subjects who received study devices and completed the initial surgical procedures. The analysis was based on the observed data and missing data due to lost-to-follow-ups were imputed. For the primary endpoint, the analysis consists of 199 investigational subjects and 160 control subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Overall Success</title>
          <description>Rate of overall success is reported as the percentage of participants who met all of the following criteria:
Postoperative Neck Disability Index (NDI) score improvement of at least a 15-point increase from preoperative;
Maintenance or improvement in neurological status;
No serious adverse event classified as implant associated or implant/surgical procedure associated; and
No additional surgical procedure classified as a “failure.”</description>
          <population>The primary analysis dataset for this study included all subjects who received study devices and completed the initial surgical procedures. The analysis was based on the observed data and missing data due to lost-to-follow-ups were imputed. For the primary endpoint, the analysis consists of 199 investigational subjects and 160 control subjects.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="199"/>
                <count group_id="O2" value="160"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.4"/>
                    <measurement group_id="O2" value="69.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis H0: p1 + d ≤ p0, and the alternative hypothesis is Ha: p1 + d &gt; p0 where P0 and P1 are the overall success rates in the control group and the investigational group respectively, and d is the non-inferiority margin. The analyses used Bayesian methodology. Should the posterior probability P(p1 – p0 &gt; -d | data) be at least 0.95, then the null non-inferiority hypothesis will be rejected, and non-inferiority of the investigational device to the control will be claimed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The non-inferiority margin is 0.1.</non_inferiority_desc>
            <p_value>1.000</p_value>
            <p_value_desc>The posterior probability of non-inferiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.113</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.022</ci_lower_limit>
            <ci_upper_limit>0.201</ci_upper_limit>
            <estimate_desc>The posterior mean of P1-P0, along with the corresponding 95% highest posterior density (HPD) interval, was presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority comparison of overall success rates in two treatment groups was a secondary objective of this trial. Superiority analysis was performed if non-inferiority was demonstrated. If the posterior probability is at least 0.95, a claim of superiority can be made.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.993</p_value>
            <p_value_desc>The posterior probability of superiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Success Rate of Neck Disability Index</title>
        <description>Success rate of Neck Disability Index is reported as the percentage of participants whose neck disability index score met the following criterion: Pre-treatment Score - Post-treatment Score ≥ 15.</description>
        <time_frame>24 months</time_frame>
        <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable NDI success status at 24 months, which leads to 199 subjects in the investigational group and 159 subjects in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Success Rate of Neck Disability Index</title>
          <description>Success rate of Neck Disability Index is reported as the percentage of participants whose neck disability index score met the following criterion: Pre-treatment Score - Post-treatment Score ≥ 15.</description>
          <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable NDI success status at 24 months, which leads to 199 subjects in the investigational group and 159 subjects in the control group.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="199"/>
                <count group_id="O2" value="159"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.9"/>
                    <measurement group_id="O2" value="79.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis H0: p1 + d ≤ p0, and the alternative hypothesis is Ha: p1 + d &gt; p0 where P0 and P1 are the NDI success rates in the control group and the investigational group respectively, and d is the non-inferiority margin. The analyses used Bayesian methodology. Should the posterior probability P (p1 - p0 &gt; -d | data) be at least 0.95, then the null non-inferiority hypothesis will be rejected, and non-inferiority of the investigational device to the control will be claimed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin is 0.1.</non_inferiority_desc>
            <p_value>1.000</p_value>
            <p_value_desc>The posterior probability of non-inferiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.088</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.012</ci_lower_limit>
            <ci_upper_limit>0.167</ci_upper_limit>
            <estimate_desc>The posterior mean of P1-P0, along with the corresponding 95% highest posterior density (HPD) interval, was presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority comparison of NDI success rates in two treatment groups was performed if non-inferiority was demonstrated.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.990</p_value>
            <p_value_desc>The posterior probability of superiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Success Rate of Neurological Status</title>
        <description>Success rate of neurological status is reported as the percentage of participants who met neurological success defined as maintenance or improvement in all sections (motor, sensory, and reflexes) for the time period evaluated. In order for a section to be considered a success, each element in the section must either remain the same or improve from the time of the preoperative evaluation to the time period evaluated.</description>
        <time_frame>24 months</time_frame>
        <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable neurological success status at 24 months, which leads to 199 subjects in the investigational group and 159 subjects in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Success Rate of Neurological Status</title>
          <description>Success rate of neurological status is reported as the percentage of participants who met neurological success defined as maintenance or improvement in all sections (motor, sensory, and reflexes) for the time period evaluated. In order for a section to be considered a success, each element in the section must either remain the same or improve from the time of the preoperative evaluation to the time period evaluated.</description>
          <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable neurological success status at 24 months, which leads to 199 subjects in the investigational group and 159 subjects in the control group.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="199"/>
                <count group_id="O2" value="159"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.5"/>
                    <measurement group_id="O2" value="86.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis H0: p1 + d ≤ p0, and the alternative hypothesis is Ha: p1 + d &gt; p0 where P0 and P1 are the neurological success rates in the control group and the investigational group respectively, and d is the non-inferiority margin. The analyses used Bayesian methodology. Should the posterior probability P (p1 - p0 &gt; -d | data) be at least 0.95, then the null non-inferiority hypothesis will be rejected, and non-inferiority of the investigational device to the control will be claimed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin is 0.1.</non_inferiority_desc>
            <p_value>1.000</p_value>
            <p_value_desc>The posterior probability of non-inferiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.05</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.014</ci_lower_limit>
            <ci_upper_limit>0.119</ci_upper_limit>
            <estimate_desc>The posterior mean of P1-P0, along with the corresponding 95% highest posterior density (HPD) interval, was presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority comparison of neurological success rates in two treatment groups was performed if non-inferiority was demonstrated.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.931</p_value>
            <p_value_desc>The posterior probability of superiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neck Pain Success Rate</title>
        <description>Numerical rating scales were used to evaluate pain intensity and frequency. The pain score (0 min, 20 max) was derived by adding the numerical rating scores from the pain intensity (0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot;) and frequency scales (0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time&quot;). Neck pain success rate is reported as the percentage of participants whose neck pain improvement met the following criterion: Preoperative Score - Postoperative Score &gt; 0.</description>
        <time_frame>24 months</time_frame>
        <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable neck pain success status at 24 months, which leads to 199 subjects in the investigational group and 159 subjects in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Neck Pain Success Rate</title>
          <description>Numerical rating scales were used to evaluate pain intensity and frequency. The pain score (0 min, 20 max) was derived by adding the numerical rating scores from the pain intensity (0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot;) and frequency scales (0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time&quot;). Neck pain success rate is reported as the percentage of participants whose neck pain improvement met the following criterion: Preoperative Score - Postoperative Score &gt; 0.</description>
          <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable neck pain success status at 24 months, which leads to 199 subjects in the investigational group and 159 subjects in the control group.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="199"/>
                <count group_id="O2" value="159"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.0"/>
                    <measurement group_id="O2" value="95.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis H0: p1 + d ≤ p0, and the alternative hypothesis is Ha: p1 + d &gt; p0 where P0 and P1 are the neck pain success rates in the control group and the investigational group respectively, and d is the non-inferiority margin. The analyses used Bayesian methodology. Should the posterior probability P (p1 - p0 &gt; -d | data) be at least 0.95, then the null non-inferiority hypothesis will be rejected, and non-inferiority of the investigational device to the control will be claimed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin is 0.1.</non_inferiority_desc>
            <p_value>1.000</p_value>
            <p_value_desc>The posterior probability of non-inferiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.021</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.019</ci_lower_limit>
            <ci_upper_limit>0.062</ci_upper_limit>
            <estimate_desc>The posterior mean of P1-P0, along with the corresponding 95% highest posterior density (HPD) interval, was presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority comparison of neck pain success rates in two treatment groups was performed if non-inferiority was demonstrated.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.852</p_value>
            <p_value_desc>The posterior probability of superiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Arm Pain Success Rate</title>
        <description>Numerical rating scales were used to evaluate pain intensity and frequency. The pain score (0 min, 20 max) was derived by adding the numerical rating scores from the pain intensity (0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot;) and frequency scales (0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time&quot;). Arm pain success rate is reported as the percentage of participants whose arm pain improvement met the following criterion: Preoperative Score - Postoperative Score &gt; 0.</description>
        <time_frame>24 months</time_frame>
        <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable arm pain success status at 24 months, which leads to 199 subjects in the investigational group and 159 subjects in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Arm Pain Success Rate</title>
          <description>Numerical rating scales were used to evaluate pain intensity and frequency. The pain score (0 min, 20 max) was derived by adding the numerical rating scores from the pain intensity (0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot;) and frequency scales (0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time&quot;). Arm pain success rate is reported as the percentage of participants whose arm pain improvement met the following criterion: Preoperative Score - Postoperative Score &gt; 0.</description>
          <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable arm pain success status at 24 months, which leads to 199 subjects in the investigational group and 159 subjects in the control group.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="199"/>
                <count group_id="O2" value="159"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.9"/>
                    <measurement group_id="O2" value="89.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis H0: p1 + d ≤ p0, and the alternative hypothesis is Ha: p1 + d &gt; p0 where P0 and P1 are the arm pain success rates in the control group and the investigational group respectively, and d is the non-inferiority margin. The analyses used Bayesian methodology. Should the posterior probability P (p1 - p0 &gt; -d | data) be at least 0.95, then the null non-inferiority hypothesis will be rejected, and non-inferiority of the investigational device to the control will be claimed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin is 0.1.</non_inferiority_desc>
            <p_value>0.997</p_value>
            <p_value_desc>The posterior probability of non-inferiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.008</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.073</ci_lower_limit>
            <ci_upper_limit>0.056</ci_upper_limit>
            <estimate_desc>The posterior mean of P1-P0, along with the corresponding 95% highest posterior density (HPD) interval, was presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority comparison of arm pain success rates in two treatment groups was performed if non-inferiority was demonstrated.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.395</p_value>
            <p_value_desc>The posterior probability of superiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Success Rate of SF-36 PCS</title>
        <description>Success rate of SF-36 Health Survey include two components: the success rate of a physical component summary (PCS) and the success rate of a mental component summary (MCS). The success of SF-36 PCS was defined as: Post Score - Pre Score &gt;= 0. The Success rate of SF-36 PCS is reported as the percentage of the participants who were classified as a success for SF-36 PCS.</description>
        <time_frame>24 months</time_frame>
        <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable SF-36 PCS success status at 24 months, which leads to 197 subjects in the investigational group and 156 subjects in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Success Rate of SF-36 PCS</title>
          <description>Success rate of SF-36 Health Survey include two components: the success rate of a physical component summary (PCS) and the success rate of a mental component summary (MCS). The success of SF-36 PCS was defined as: Post Score - Pre Score &gt;= 0. The Success rate of SF-36 PCS is reported as the percentage of the participants who were classified as a success for SF-36 PCS.</description>
          <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable SF-36 PCS success status at 24 months, which leads to 197 subjects in the investigational group and 156 subjects in the control group.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="197"/>
                <count group_id="O2" value="156"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.4"/>
                    <measurement group_id="O2" value="87.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis H0: p1 + d ≤ p0, and the alternative hypothesis is Ha: p1 + d &gt; p0 where P0 and P1 are the SF-36 PCS success rates in the control group and the investigational group respectively, and d is the non-inferiority margin. The analyses used Bayesian methodology. Should the posterior probability P (p1 - p0 &gt; -d | data) be at least 0.95, then the null non-inferiority hypothesis will be rejected, and non-inferiority of the investigational device to the control will be claimed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin is 0.1.</non_inferiority_desc>
            <p_value>1.000</p_value>
            <p_value_desc>The posterior probability of non-inferiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.024</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.042</ci_lower_limit>
            <ci_upper_limit>0.088</ci_upper_limit>
            <estimate_desc>The posterior mean of P1-P0, along with the corresponding 95% highest posterior density (HPD) interval, was presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority comparison of SF-36 PCS success rates in two treatment groups was performed if non-inferiority was demonstrated.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.767</p_value>
            <p_value_desc>The posterior probability of superiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Success Rate of SF-36 MCS</title>
        <description>Success rate of SF-36 Health Survey include two components: the success rate of a physical component summary (PCS) and the success rate of a mental component summary (MCS). The success of SF-36 MCS were defined as: Post Score - Pre Score &gt;= 0. The Success rate of SF-36 MCS is reported as the percentage of the participants who were classified as a success for SF-36 MCS.</description>
        <time_frame>24 months</time_frame>
        <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable SF-36 MCS success status at 24 months, which leads to 197 subjects in the investigational group and 156 subjects in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Success Rate of SF-36 MCS</title>
          <description>Success rate of SF-36 Health Survey include two components: the success rate of a physical component summary (PCS) and the success rate of a mental component summary (MCS). The success of SF-36 MCS were defined as: Post Score - Pre Score &gt;= 0. The Success rate of SF-36 MCS is reported as the percentage of the participants who were classified as a success for SF-36 MCS.</description>
          <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable SF-36 MCS success status at 24 months, which leads to 197 subjects in the investigational group and 156 subjects in the control group.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="197"/>
                <count group_id="O2" value="156"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.0"/>
                    <measurement group_id="O2" value="72.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis H0: p1 + d ≤ p0, and the alternative hypothesis is Ha: p1 + d &gt; p0 where P0 and P1 are the SF-36 MCS success rates in the control group and the investigational group respectively, and d is the non-inferiority margin. The analyses used Bayesian methodology. Should the posterior probability P (p1 - p0 &gt; -d | data) be at least 0.95, then the null non-inferiority hypothesis will be rejected, and non-inferiority of the investigational device to the control will be claimed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin is 0.1.</non_inferiority_desc>
            <p_value>0.945</p_value>
            <p_value_desc>The posterior probability of non-inferiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.024</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.120</ci_lower_limit>
            <ci_upper_limit>0.067</ci_upper_limit>
            <estimate_desc>The posterior mean of P1-P0, along with the corresponding 95% highest posterior density (HPD) interval, was presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Disc Height Success</title>
        <description>Disc height was assessed by determining the Functional Spinal Unit (FSU) height. The rate of disc height success is reported as the percentage of participants whose disc height for each level based on either the anterior or posterior measurements met the following criterion: Postoperative Height - 6 Week Postoperative Height &gt;= -2mm</description>
        <time_frame>24 months</time_frame>
        <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable disc height success (FSU success) status at 24 months, which leads to 170 subjects in the investigational group and 138 subjects in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Disc Height Success</title>
          <description>Disc height was assessed by determining the Functional Spinal Unit (FSU) height. The rate of disc height success is reported as the percentage of participants whose disc height for each level based on either the anterior or posterior measurements met the following criterion: Postoperative Height - 6 Week Postoperative Height &gt;= -2mm</description>
          <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable disc height success (FSU success) status at 24 months, which leads to 170 subjects in the investigational group and 138 subjects in the control group.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="170"/>
                <count group_id="O2" value="138"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.5"/>
                    <measurement group_id="O2" value="95.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis H0: p1 + d ≤ p0, and the alternative hypothesis is Ha: p1 + d &gt; p0 where P0 and P1 are the FSU success rates in the control group and the investigational group respectively, and d is the non-inferiority margin. The analyses used Bayesian methodology. Should the posterior probability P (p1 - p0 &gt; -d | data) be at least 0.95, then the null non-inferiority hypothesis will be rejected, and non-inferiority of the investigational device to the control will be claimed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin is 0.1.</non_inferiority_desc>
            <p_value>0.997</p_value>
            <p_value_desc>The posterior probability of non-inferiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.017</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.072</ci_lower_limit>
            <ci_upper_limit>0.040</ci_upper_limit>
            <estimate_desc>The posterior mean of P1-P0, along with the corresponding 95% highest posterior density (HPD) interval, was presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority comparison of FSU success rates in two treatment groups was performed if non-inferiority was demonstrated.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.271</p_value>
            <p_value_desc>The posterior probability of superiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Gait Success Rate</title>
        <description>Patient's gait was assessed by using Nurick's classification, and indicated either as normal or graded on a scale of 0 to 5. Success was defined as maintenance or improvement in the postoperative status as compared to the preoperative condition: Preoperative Score - Postoperative Score &gt;= 0. The gait success rate is reported as the percentage of participants who had gait success.</description>
        <time_frame>24 months</time_frame>
        <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable gait success status at 24 months, which leads to 199 subjects in the investigational group and 159 subjects in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Gait Success Rate</title>
          <description>Patient's gait was assessed by using Nurick's classification, and indicated either as normal or graded on a scale of 0 to 5. Success was defined as maintenance or improvement in the postoperative status as compared to the preoperative condition: Preoperative Score - Postoperative Score &gt;= 0. The gait success rate is reported as the percentage of participants who had gait success.</description>
          <population>For this endpoint, the analysis consists of subjects in the primary analysis dataset with evaluable gait success status at 24 months, which leads to 199 subjects in the investigational group and 159 subjects in the control group.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="199"/>
                <count group_id="O2" value="159"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0"/>
                    <measurement group_id="O2" value="98.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis H0: p1 + d ≤ p0, and the alternative hypothesis is Ha: p1 + d &gt; p0 where P0 and P1 are the gait success rates in the control group and the investigational group respectively, and d is the non-inferiority margin. The analyses used Bayesian methodology. Should the posterior probability P (p1 - p0 &gt; -d | data) be at least 0.95, then the null non-inferiority hypothesis will be rejected, and non-inferiority of the investigational device to the control will be claimed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin is 0.1.</non_inferiority_desc>
            <p_value>1.000</p_value>
            <p_value_desc>The posterior probability of non-inferiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.013</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.013</ci_lower_limit>
            <ci_upper_limit>0.040</ci_upper_limit>
            <estimate_desc>The posterior mean of P1-P0, along with the corresponding 95% highest posterior density (HPD) interval, was presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority comparison of gait success rates in two treatment groups was performed if non-inferiority was demonstrated.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.859</p_value>
            <p_value_desc>The posterior probability of superiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operative Time</title>
        <description>Operative time was recorded from skin incision to wound closure.</description>
        <time_frame>Time of operation, an average of 1.7-2.1hrs</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Operative Time</title>
          <description>Operative time was recorded from skin incision to wound closure.</description>
          <units>hrs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="0.8"/>
                    <measurement group_id="O2" value="1.7" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority comparison of the operative time in two treatment groups was assessed. The null hypothesis is H0: μ1 = μ0 and the alternative hypothesis is Ha: μ1 ≠ μ0, where μ0 and μ1 denote the mean in control group the investigational group, respectively. Should the posterior probability of superiority P(μ1– μ0 &lt; 0|data) be at least 97.5%, the superiority would be claimed.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0</p_value>
            <p_value_desc>The posterior probably of superiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
            <param_type>Posterior Mean Difference</param_type>
            <param_value>0.400</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.252</ci_lower_limit>
            <ci_upper_limit>0.548</ci_upper_limit>
            <estimate_desc>The posterior mean difference (µ1- µ0) and the corresponding 95% highest posterior density (HPD) interval were presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Loss</title>
        <time_frame>During the time of operation, an average of 1.7-2.1 hrs</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Loss</title>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="208"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.2" spread="64.1"/>
                    <measurement group_id="O2" value="55.7" spread="46.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority comparison of the blood loss in two treatment groups was assessed.The null hypothesis is H0: μ1 = μ0 and the alternative hypothesis is Ha: μ1 ≠ μ0, where μ0 and μ1 denote the mean in control group the investigational group, respectively. Should the posterior probability of superiority P(μ1– μ0 &lt; 0|data) be at least 97.5%, the superiority would be claimed.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Bayesian model</method>
            <param_type>Posterior Mean Difference</param_type>
            <param_value>11.500</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.560</ci_lower_limit>
            <ci_upper_limit>22.440</ci_upper_limit>
            <estimate_desc>The posterior mean difference (µ1- µ0) and the corresponding 95% highest posterior density (HPD) interval were presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Stay</title>
        <time_frame>From admission to discharge, an average of 1.0-1.5 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Stay</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.5"/>
                    <measurement group_id="O2" value="1.3" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Superiority comparison of the hospital stay in two treatment groups was assessed.The null hypothesis is H0: μ1 = μ0 and the alternative hypothesis is Ha: μ1 ≠ μ0, where μ0 and μ1 denote the mean in control group the investigational group, respectively. Should the posterior probability of superiority P(μ1– μ0 &lt; 0|data) be at least 97.5%, the superiority would be claimed.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.892</p_value>
            <p_value_desc>The posterior probably of superiority was calculated and presented instead of the p-value.</p_value_desc>
            <method>Bayesian model</method>
            <param_type>Posterior Mean Difference</param_type>
            <param_value>-0.100</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.258</ci_lower_limit>
            <ci_upper_limit>0.058</ci_upper_limit>
            <estimate_desc>The posterior mean difference (µ1- µ0) and the corresponding 95% highest posterior density (HPD) interval were presented instead of the usual 95% CI.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Secondary Surgery at Index Level</title>
        <description>Secondary surgical procedures at the index level included revisions, removals, supplemental fixations and reoperations. Rate of secondary surgery at index level is reported as percentage of subjects who had secondary surgeries at index level.</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Secondary Surgery at Index Level</title>
          <description>Secondary surgical procedures at the index level included revisions, removals, supplemental fixations and reoperations. Rate of secondary surgery at index level is reported as percentage of subjects who had secondary surgeries at index level.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4"/>
                    <measurement group_id="O2" value="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Neck Disability Index Score From Baseline</title>
        <description>The self-administered Neck Disability Index (NDI) Questionnaire was used to assess patient neck pain and ability to function. The NDI scale ranges from 0-100. The best score is 0 (no disability) and worst is 100 (maximum disability). Change of NDI was defined as NDI at 24 month minus NDI at baseline.</description>
        <time_frame>Baseline and 24 months post-operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Neck Disability Index Score From Baseline</title>
          <description>The self-administered Neck Disability Index (NDI) Questionnaire was used to assess patient neck pain and ability to function. The NDI scale ranges from 0-100. The best score is 0 (no disability) and worst is 100 (maximum disability). Change of NDI was defined as NDI at 24 month minus NDI at baseline.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NDI at baseline (n=209, 188)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.1" spread="13.4"/>
                    <measurement group_id="O2" value="53.2" spread="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NDI at 24 months (n=199, 159)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0" spread="16.6"/>
                    <measurement group_id="O2" value="20.0" spread="20.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NDI change (n=199, 159)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-37.0" spread="17.8"/>
                    <measurement group_id="O2" value="-32.5" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Neck Pain Score From Baseline</title>
        <description>Numerical rating scales were used to evaluate neck pain intensity and frequency. Subjects rated their neck pain intensity on a scale from 0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot; Similarly, subjects recorded their neck pain frequency on a scale from 0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time.&quot; The total neck pain score (0 to 20) was the addition of pain intensity and frequency scores. Change of neck pain score was defined as neck pain score at 24 months minus neck pain score at baseline.</description>
        <time_frame>Baseline and 24 months post-operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Neck Pain Score From Baseline</title>
          <description>Numerical rating scales were used to evaluate neck pain intensity and frequency. Subjects rated their neck pain intensity on a scale from 0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot; Similarly, subjects recorded their neck pain frequency on a scale from 0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time.&quot; The total neck pain score (0 to 20) was the addition of pain intensity and frequency scores. Change of neck pain score was defined as neck pain score at 24 months minus neck pain score at baseline.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Neck pain at baseline (n=209, 188)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.2" spread="2.9"/>
                    <measurement group_id="O2" value="16.3" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neck pain at 24 months (n=199, 159)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="4.9"/>
                    <measurement group_id="O2" value="5.9" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neck pain change (n=199, 159)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.8" spread="5.2"/>
                    <measurement group_id="O2" value="-10.3" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of Arm Pain Score From Baseline</title>
        <description>Numerical rating scales were also used to evaluate arm pain intensity and frequency. Subjects rated their arm pain intensity on a scale from 0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot; Similarly, subjects recorded their arm pain frequency on a scale from 0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time.&quot; The total arm pain score (0 to 20) was the addition of pain intensity and frequency scores. Change of arm pain score was defined as arm pain score at 24 months minus arm pain score at baseline.</description>
        <time_frame>Baseline and 24 months post-operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Arm Pain Score From Baseline</title>
          <description>Numerical rating scales were also used to evaluate arm pain intensity and frequency. Subjects rated their arm pain intensity on a scale from 0-10, with a score of 0 representing &quot;no pain&quot; and a score of 10 representing &quot;pain as bad as it could be.&quot; Similarly, subjects recorded their arm pain frequency on a scale from 0-10, with a score of 0 being &quot;pain none of the time&quot; and a score of 10 being &quot;pain all of the time.&quot; The total arm pain score (0 to 20) was the addition of pain intensity and frequency scores. Change of arm pain score was defined as arm pain score at 24 months minus arm pain score at baseline.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Arm pain at baseline (n=209, 188)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.8" spread="5.6"/>
                    <measurement group_id="O2" value="14.4" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arm pain at 24 months (n=199, 159)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="4.8"/>
                    <measurement group_id="O2" value="4.0" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arm pain change (n=199, 159)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.9" spread="6.7"/>
                    <measurement group_id="O2" value="-10.2" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of General Health Status -- SF-36 PCS From Baseline</title>
        <description>The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results were summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS was between 0 and 100, with higher scores denoting better quality of life. Change of SF-36 PCS score was defined as PCS score at 24 months minus PCS score at baseline.</description>
        <time_frame>Baseline and 24 months post-operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of General Health Status -- SF-36 PCS From Baseline</title>
          <description>The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results were summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS was between 0 and 100, with higher scores denoting better quality of life. Change of SF-36 PCS score was defined as PCS score at 24 months minus PCS score at baseline.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>SF-36 PCS at baseline (n=209, 188)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.8" spread="7.8"/>
                    <measurement group_id="O2" value="30.8" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF-36 PCS at 24 months (n=197, 156)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.3" spread="10.7"/>
                    <measurement group_id="O2" value="45.4" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF-36 PCS change (n=197, 156)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.3" spread="11.5"/>
                    <measurement group_id="O2" value="13.8" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change of General Health Status -- SF-36 MCS From Baseline</title>
        <description>The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results were summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for MCS was between 0 and 100, with higher scores denoting better quality of life. Change of SF-36 MCS score was defined as MCS score at 24 months minus MCS score at baseline.</description>
        <time_frame>Baseline and 24 months post-operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRESTIGE LP Device</title>
            <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
          </group>
          <group group_id="O2">
            <title>ATLANTIS Cervical Plate System</title>
            <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of General Health Status -- SF-36 MCS From Baseline</title>
          <description>The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was used to assess general health status. The SF-36 results were summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for MCS was between 0 and 100, with higher scores denoting better quality of life. Change of SF-36 MCS score was defined as MCS score at 24 months minus MCS score at baseline.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>SF-36 MCS at baseline (n=209, 188)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.9" spread="11.8"/>
                    <measurement group_id="O2" value="43.8" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF-36 MCS at 24 months (n=197, 156)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.1" spread="10.8"/>
                    <measurement group_id="O2" value="50.9" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF-36 MCS change (n=197, 156)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="14.5"/>
                    <measurement group_id="O2" value="6.9" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>up to 24 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>PRESTIGE LP Device</title>
          <description>PRESTIGE LP device at two adjacent levels: PRESTIGE LP is a prosthetic device intended to replace a damaged disc in the cervical spine and intended to act as an intervertebral body spacer rather than a fusion device. It is inserted using an anterior surgical approach.</description>
        </group>
        <group group_id="E2">
          <title>ATLANTIS Cervical Plate System</title>
          <description>Bi-level fusion with ATLANTIS Cervical Plate System: Bi-level anterior cervical fusion procedure involving cortical ring allograft and the ATLANTIS Cervical Plate System.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="72" subjects_at_risk="209"/>
                <counts group_id="E2" subjects_affected="90" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tricuspid valve incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Arnold-Chiari malformation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Chronic granulomatous disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Myocardial bridging</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spine malformation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Thyrotoxic crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blindness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cataract subcapsular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal adhesions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Anal fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Mesenteric occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Oesophageal disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tooth loss</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Abasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Device breakage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Device connection issue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Facial pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Feeling abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sensation of pressure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Biliary dyskinesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Enterobacter infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lyme disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Skin graft infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Burns third degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cartilage injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Corneal abrasion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cranial nerve injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dural tear</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="209"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Flatback syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Incision site haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Kyphosis postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ligament injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Limb crushing injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lip injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Meniscus lesion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nail avulsion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Open wound</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pneumothorax traumatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural nausea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural vomiting</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sports injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tendon injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Traumatic lung injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Arthroscopy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Blood glucose fluctuation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bone scan abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Computerised tomogram abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Drug screen positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Electrocardiogram abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Foetal heart rate abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Foetal monitoring</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Grip strength decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Haematocrit decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lymphocyte count decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neurological examination abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nuclear magnetic resonance imaging abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal X-ray abnormal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>X-ray of pelvis and hip abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="209"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Facet joint syndrome</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="209"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="209"/>
                <counts group_id="E2" events="20" subjects_affected="18" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intervertebral disc space narrowing</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Joint crepitation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Joint range of motion decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ligament disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Musculoskeletal discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Musculoskeletal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="209"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pseudarthrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Scoliosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="209"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Synovitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vertebral foraminal stenosis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="209"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Burning sensation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cerebral atrophy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cerebral hypoperfusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cervical cord compression</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cervical myelopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Complex regional pain syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cubital tunnel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intracranial hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nerve root compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Peroneal nerve palsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Radicular pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Radiculitis brachial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sensory loss</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal claudication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal cord compression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tongue paralysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Aggression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Drug dependence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Emotional distress</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lower urinary tract symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Haemorrhagic ovarian cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Uterine enlargement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vaginal discharge</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nasal septum deviation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nasal septum perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pleural fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Respiratory depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Telangiectasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Tobacco user</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Bunion operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Carpal tunnel decompression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastric banding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hysterectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Peripheral nerve decompression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Prolapse repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Rotator cuff repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Skin graft</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal decompression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal fusion surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vascular stent insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="191" subjects_at_risk="209"/>
                <counts group_id="E2" subjects_affected="171" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Splenomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bundle branch block left</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Congenital choroid plexus cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spine malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Eustachian tube dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blepharospasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Conjunctival discolouration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Eye swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Macular degeneration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Papilloedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Scintillating scotoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Acquired oesophageal web</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cheilitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="209"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Eructation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Functional gastrointestinal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastrointestinal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastrointestinal sounds abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intestinal polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Loose tooth</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="209"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Odynophagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Salivary gland mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tooth erosion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Complication of device insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Device breakage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Device connection issue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Device deployment issue</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Face oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Feeling cold</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Local swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Localised oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Medical device discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="209"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Secretion discharge</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sensation of foreign body</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tenderness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Biliary dyskinesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gallbladder disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hepatic cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Klebsiella infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Onychomycosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Stitch abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Streptococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Accident at home</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cartilage injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Epicondylitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Epidural fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="15" subjects_affected="13" subjects_at_risk="209"/>
                <counts group_id="E2" events="24" subjects_affected="16" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Heat exhaustion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Inadequate osteointegration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Incision site complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Incision site erythema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Incision site haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Incision site hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Incision site oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Incision site pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="209"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ligament injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Limb crushing injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Meniscus lesion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neck injury</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nerve injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nerve root injury cervical</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nerve root injury lumbar</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nerve root injury sacral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Periorbital haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Post lumbar puncture syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural nausea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural site reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Procedural vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Repetitive strain injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="209"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Soft tissue injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sports injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tendon injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ulnar nerve injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Urinary retention postoperative</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Wound complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Wound secretion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Angiogram cerebral abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bacterial test positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Biopsy mucosa normal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Biopsy oesophagus normal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Blood cholesterol increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Blood cortisol decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Blood triglycerides increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bone scan abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Computerised tomogram abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>False positive investigation result</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Glomerular filtration rate decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Glycosylated haemoglobin increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Grip strength decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>High density lipoprotein decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lasegue's test positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lipids increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Mean cell haemoglobin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neurological examination</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neurological examination abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nuclear magnetic resonance imaging abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Orthopedic examination abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Scan abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Scan bone marrow abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sensory level abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal X-ray abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Staphylococcus test positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Stress echocardiogram abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Urine output decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>X-ray abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>X-ray limb abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hyperlipidaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vitamin B12 deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vitamin C deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vitamin D deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="21" subjects_affected="18" subjects_at_risk="209"/>
                <counts group_id="E2" events="20" subjects_affected="18" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="37" subjects_affected="34" subjects_at_risk="209"/>
                <counts group_id="E2" events="39" subjects_affected="35" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bone erosion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bursa disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cervical spine flattening</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Chondropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Coccydynia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" events="19" subjects_affected="17" subjects_at_risk="209"/>
                <counts group_id="E2" events="13" subjects_affected="11" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Facet joint syndrome</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="209"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="209"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="14" subjects_affected="12" subjects_at_risk="209"/>
                <counts group_id="E2" events="24" subjects_affected="19" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Intervertebral disc space narrowing</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Jaw disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Joint crepitation</sub_title>
                <counts group_id="E1" events="23" subjects_affected="19" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Joint lock</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Joint range of motion decreased</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="209"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Kyphosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Limb discomfort</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Muscle atrophy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="25" subjects_affected="23" subjects_at_risk="209"/>
                <counts group_id="E2" events="16" subjects_affected="12" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Muscle tightness</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="209"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Muscle twitching</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="209"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Musculoskeletal discomfort</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="209"/>
                <counts group_id="E2" events="11" subjects_affected="8" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Musculoskeletal disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="59" subjects_affected="51" subjects_at_risk="209"/>
                <counts group_id="E2" events="46" subjects_affected="39" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" events="18" subjects_affected="16" subjects_at_risk="209"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="209"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Myofascial pain syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="82" subjects_affected="64" subjects_at_risk="209"/>
                <counts group_id="E2" events="77" subjects_affected="60" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="209"/>
                <counts group_id="E2" events="17" subjects_affected="12" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Osteolysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Osteopenia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="51" subjects_affected="41" subjects_at_risk="209"/>
                <counts group_id="E2" events="58" subjects_affected="50" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Patellofemoral pain syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pelvic deformity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Plantar fasciitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pseudarthrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="209"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sacroiliitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Scoliosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sensation of heaviness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal deformity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal fusion acquired</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="209"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spondylolysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Syndesmophyte</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Synovitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Systemic lupus erythematosus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Temporomandibular joint syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tendon disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Trigger finger</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Trismus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vertebral foraminal stenosis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="209"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Benign nipple neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neurofibroma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pituitary tumour recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Seborrhoeic keratosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Skin papilloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Spinal haemangioma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Aphonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Areflexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Aura</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Benign intracranial hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Brachial plexopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Burning sensation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="209"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cerebral small vessel ischaemic disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cervical cord compression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cervicogenic headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Complex regional pain syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cubital tunnel syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Demyelination</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dysaesthesia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dyskinesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Extensor plantar response</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Gait spastic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Head discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Head titubation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="33" subjects_affected="31" subjects_at_risk="209"/>
                <counts group_id="E2" events="44" subjects_affected="35" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hyperreflexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="55" subjects_affected="42" subjects_at_risk="209"/>
                <counts group_id="E2" events="47" subjects_affected="38" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hyporeflexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Muscle contractions involuntary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nerve root compression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nerve root lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neuritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neurological decompensation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Occipital neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="42" subjects_affected="33" subjects_at_risk="209"/>
                <counts group_id="E2" events="17" subjects_affected="16" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Periodic limb movement disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Radial nerve compression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Radicular pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Radicular syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Radiculitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Radiculitis lumbosacral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Restless legs syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sensory disturbance</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sensory loss</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="209"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Syringomyelia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tinel's sign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vocal cord paralysis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vocal cord paresis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Anxiety disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Drug dependence</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Emotional distress</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Initial insomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Post-traumatic stress disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Psychosomatic disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Somatoform disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bladder dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cystitis interstitial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Micturition urgency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Renal disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Breast discharge</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Breast fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Breast mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Breast pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Breast tenderness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cervical dysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Endometriosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Menopausal symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Menstrual disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ovarian mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Testicular pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Varicocele</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vulvovaginal burning sensation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vulvovaginal pruritus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Apnoeic attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Laryngospasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Nasal discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="209"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Painful respiration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pharyngeal erythema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pharyngeal mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Reflux laryngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Respiratory tract congestion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Rhinitis seasonal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sinus disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Snoring</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Throat tightness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Actinic keratosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ingrowing nail</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Ingrown hair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lentigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="209"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Scar</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sebaceous gland disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Skin reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Canalith repositioning procedure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Colon polypectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Sinus operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Urostomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="209"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Peripheral coldness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Vasodilatation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Venous insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Department</name_or_title>
      <organization>Medtronic Spine and biologics</organization>
      <phone>1800-876-3133 ext 6068</phone>
      <email>msbkclinicalresearch@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

